Glucocorticoid therapy and risk of bladder cancer

This publication has 36 references indexed in Scilit:

• Selenium and Risk of Bladder Cancer: A Population-Based Case-Control Study
  Cancer Prevention Research, 2009
• Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case–control study
  British Journal of Cancer, 2008
• Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation
  British Journal of Cancer, 2008
• Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study
  BMC Urology, 2007
• Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: A rare, but intriguing association. Two case reports and literature review
  Scandinavian Journal of Infectious Diseases, 2006
• Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma
  Clinical Rheumatology, 2004
• Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide
  Annals of the Rheumatic Diseases, 2004
• Epidemiology and etiology of bladder cancer
  Seminars in Surgical Oncology, 1997
• Bladder and Kidney Cancer Following Cyclophosphamide Therapy for Non-Hodgkin's Lymphoma
  JNCI: Journal of the National Cancer Institute, 1995
• Cancer incidence in a kidney-transplanted population
  Transplant International, 1994